Interpace Diagnostics Implements Broad Based Efficiencies and Cost-Cutting Measures Resulting in Significant 2016 Savings Mar 23, 2016
Interpace Diagnostics Announces Agreement with America's Choice Provider Network to Cover All of the Company's Molecular Tests for Thyroid and Pancreatic Cancer Mar 1, 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR™ Micro RNA Gene Expression Classifer Feb 17, 2016
Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts Jan 20, 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp Jan 12, 2016
